Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  114,932 نتائج ل ""Antibodies, Monoclonal""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience.

  • Authors : Rizzo M; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy.; Morelli F

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

  • Source: Cancer medicine [Cancer Med] 2025 Feb; Vol. 14 (4), pp. e70479.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients.

  • Authors : Szabo E; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Anaesthesiology, Harvard Medical School, Boston, MA, USA.

Subjects: Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/drug therapy ; Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/physiopathology ; Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/diagnostic imaging

  • Source: Cephalalgia : an international journal of headache [Cephalalgia] 2025 Feb; Vol. 45 (2), pp. 3331024241313377.Publisher: Country of Publication: England NLM ID: 8200710 Publication Model: Print Cited Medium: Internet ISSN: 1468-2982 (Electronic)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Dual biological treatments in immune-mediated disorders: a single center experience.

  • Authors : Shamriz O; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. .; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. .

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Biological Therapy*/Biological Therapy*/Biological Therapy*/methods

  • Source: BMC immunology [BMC Immunol] 2025 Apr 08; Vol. 26 (1), pp. 29. Date of Electronic Publication: 2025 Apr 08.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

IL-17 Inhibitor Secukinumab Achieves Remission in Relapsing Polychondritis: A Case Report.

  • Authors : Neycheva S; Department of Rheumatology, Military Medical Academy, Sofia, Bulgaria.; Kamburova A

Subjects: Polychondritis, Relapsing*/Polychondritis, Relapsing*/Polychondritis, Relapsing*/drug therapy ; Polychondritis, Relapsing*/Polychondritis, Relapsing*/Polychondritis, Relapsing*/complications ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: The American journal of case reports [Am J Case Rep] 2025 Mar 20; Vol. 26, pp. e946916. Date of Electronic Publication: 2025 Mar 20.Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 101489566 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The effect of IL-1β inhibitor canakinumab (Ilaris®) on IL-6 production in human skeletal muscle cells.

Subjects: Interleukin-1beta*/Interleukin-1beta*/Interleukin-1beta*/metabolism ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology ; Interleukin-6*/Interleukin-6*/Interleukin-6*/metabolism

  • Source: PloS one [PLoS One] 2025 Mar 06; Vol. 20 (3), pp. e0316110. Date of Electronic Publication: 2025 Mar 06 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Physiology-based pharmacokinetic model with relative transcriptomics to evaluate tissue distribution and receptor occupancy of anifrolumab.

  • Authors : Sharma P; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Boulton DW

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacokinetics ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2025 Jan; Vol. 14 (1), pp. 105-117. Date of Electronic Publication: 2024 Oct 03.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibody.

  • Authors : White JT; Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA. .; Terstappen J

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/immunology

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Dec 18; Vol. 24 (1), pp. 1403. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Benefit-risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene-related peptide monoclonal antibodies.

  • Authors : Ailani J; MedStar Georgetown University Hospital, Washington, DC, USA.; Lalla A

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects ; Calcitonin Gene-Related Peptide*/Calcitonin Gene-Related Peptide*/Calcitonin Gene-Related Peptide*/antagonists & inhibitors

  • Source: Cephalalgia : an international journal of headache [Cephalalgia] 2024 Nov; Vol. 44 (11), pp. 3331024241299377.Publisher: Country of Publication: England NLM ID: 8200710 Publication Model: Print Cited Medium: Internet ISSN: 1468-2982 (Electronic)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A model-based approach using GSK3772847, an anti-interleukin-33 receptor monoclonal antibody, as a showcase to predict SC administration PK and free target dynamics based on PK and total target measurements after IV administration.

  • Authors : Berkhout J; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands.; Fairman D

Subjects: Administration, Intravenous* ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacokinetics ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/administration & dosage

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2025 Jan; Vol. 14 (1), pp. 17-27. Date of Electronic Publication: 2024 Sep 11.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives.

  • Authors : Kim BH; Department of Biochemistry, College of Medicine, Konyang University, 158, Gwanjeodong-Ro Seo-Gu, Daejeon, 35365, Republic of Korea.; Kim S

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/immunology ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use

  • Source: Translational neurodegeneration [Transl Neurodegener] 2025 Jan 27; Vol. 14 (1), pp. 6. Date of Electronic Publication: 2025 Jan 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101591861 Publication Model: Electronic Cited Medium: Print ISSN: 2047-9158

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  114,932 نتائج ل ""Antibodies, Monoclonal""